Loratadine tablets manufactured using direct compression commonly incorporate excipients such as microcrystalline cellulose, lactose, and magnesium stearate [1]. Microcrystalline cellulose often functions as a binder and filler, while lactose serves as a diluent. Magnesium stearate is typically used as a lubricant to prevent the mixture from sticking to manufacturing equipment [1].
What other excipients are used in loratadine tablets?
Besides the primary excipients, other ingredients may be included depending on the specific formulation. These can include disintegrants, which help the tablet break apart in the digestive tract, and glidants, which improve powder flow during manufacturing [1].
How does direct compression differ from other tablet manufacturing methods?
Direct compression is a tablet manufacturing process where a blend of active pharmaceutical ingredients and excipients is compressed directly into tablets without prior granulation [2]. This contrasts with wet granulation, where the powder mixture is moistened and then dried, or dry granulation, where the powder is compacted into slugs or sheets before milling and compression [2]. Direct compression is often favored for its simplicity and cost-effectiveness, requiring fewer steps and less equipment [2].
When do patents for loratadine expire?
Loratadine, the active ingredient in Claritin, has long been off-patent. The original patents for loratadine expired decades ago, allowing for the widespread availability of generic versions [3].
Can generic loratadine tablets be made using direct compression?
Yes, generic loratadine manufacturers frequently utilize direct compression techniques due to its efficiency and cost advantages [1][2]. The availability of generic loratadine is a direct result of patent expiries [3].
Who are the major manufacturers of loratadine?
A variety of pharmaceutical companies manufacture and market loratadine tablets, both branded and generic. Companies such as Bayer (original developer of Claritin), and numerous generic manufacturers produce loratadine products [4].
What are the advantages of direct compression manufacturing for loratadine?
Direct compression offers several benefits for loratadine tablet production. It streamlines the manufacturing process by eliminating granulation steps, which can reduce manufacturing time and energy consumption [2]. This method also helps maintain the stability of heat-sensitive or moisture-sensitive ingredients, although loratadine itself is relatively stable [1][2]. The overall reduction in processing steps can also lead to lower production costs [2].
What are the challenges of direct compression for loratadine?
While advantageous, direct compression requires excipients with good flow and compressibility properties [1]. If the blend of loratadine and excipients does not possess these characteristics, issues such as poor tablet hardness, capping, or sticking can arise [1][2]. Careful selection and testing of excipients are therefore crucial for successful direct compression manufacturing of loratadine tablets.
How is the quality of loratadine tablets ensured?
Quality control measures for loratadine tablets, regardless of the manufacturing method, include testing for tablet weight variation, hardness, thickness, disintegration time, and dissolution rate [1]. These tests ensure that each tablet contains the correct dose of loratadine and will release it appropriately in the body [1]. Regulatory bodies like the U.S. Food and Drug Administration (FDA) set standards that manufacturers must meet [5].
What is the mechanism of action for loratadine?
Loratadine is a selective, long-acting antihistamine that acts as a peripheral H1-receptor antagonist [6]. It works by blocking the action of histamine, a substance released by the body during allergic reactions, thereby reducing symptoms such as sneezing, runny nose, itchy eyes, and hives [6].
Sources:
[1] DrugPatentWatch.com
[2] https://www.drugpatentwatch.com/drug-manufacturing/direct-compression
[3] https://www.drugpatentwatch.com/drug/loratadine
[4] https://www.drugpatentwatch.com/drug/claritin
[5] https://www.drugpatentwatch.com/drug-regulation
[6] https://www.drugpatentwatch.com/drug-mechanism-of-action/loratadine